D. Jeffrey Keyser
Director · Lantern Pharma Inc.
- 2025
- May 14, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies D. Jeffrey Keyser files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Lee Troy Schalop - $100K in LTRN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is D. Jeffrey Keyser?
D. Jeffrey Keyser is a corporate insider, tracked as Director of Lantern Pharma Inc. (LTRN). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did D. Jeffrey Keyser last file a Form 4?
The most recent primary Form 4 on record is dated 14 May 2026, one of 3 filings going back to 2025.
Has D. Jeffrey Keyser been buying or selling stock?
Recorded transactions: 2 open-market purchases ($100K) and 0 open-market sales across all tracked filings.
